news
Long-term use of PPIs linked to stomach cancer
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer...
List view / Grid view
Cancer
news
Sandoz proposed biosimilar pegfilgrastim accepted by EMA
Sandoz has announced that its biosimilar pegfilgrastim has been accepted by the EMA for regulatory review...
news
FDA approves Yescarta to treat adults with B-cell lymphoma
The FDA has approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma...
news
NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
news
PI3K inhibitors show hope for rare bone cancers
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
news
Neratinib defeats the Ras genes notorious for causing cancer
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
news
TLR agonists suppress tumour growth
TLR agonists injected directly into a tumour suppresses tumour growth throughout the whole body...
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
Proposed guidelines for handling CAR-T cell side effects
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects...
news
Chemotherapy pain may be eased by jet-lag drug
Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag...
news
ALA-artemisinin combination therapy for cancer identified
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
news
FDA approves first biosimilar for the treatment of cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
news
Cancer drug stimulates tripolar mode of mitosis
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
news
Zika virus shown to kill brain cancer stem cells
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma
news
Combination of conventional drugs enhances tumour cell death
Brazilian researchers have investigated whether cisplatin and 5-FU would interfere with the protein pRB...
